(Q21284776)

English

AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients

scientific article

AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

In more languages

edit

Statements

1 reference

13 November 2016

AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients (English)

1 reference

13 November 2016

0 references

0 references

1 reference

4

Borivoj

Vojtesek

Borivoj Vojtesek

1 reference

22 August 2022

Roman Hrstka

1

Roman

Hrstka

1 reference

22 August 2022

Veronika Brychtova

series ordinal

2

author given names

Veronika

author last names

Brychtova

1 reference

22 August 2022

Pavel Fabian

series ordinal

3

author given names

Pavel

author last names

Fabian

1 reference

22 August 2022

Marek Svoboda

series ordinal

5

author given names

Marek

author last names

Svoboda

1 reference

22 August 2022

language of work or name

English

0 references

publication date

2013

0 references

published in

Disease Markers

0 references

volume

35

0 references

issue

4

0 references

page(s)

207-12

0 references

copyright license

Creative Commons Attribution 3.0 Unported

start time

1 January 2013

1 reference

stated in

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

stated in

April 2022 Public Data File from Crossref

cites work

Data-independent proteomic screen identifies novel tamoxifen agonist that mediates drug resistance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

19 March 2017

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

19 March 2017

The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

19 March 2017

Global cancer statistics, 2002

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

19 March 2017

Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

19 March 2017

Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

Therapeutic targeting in the estrogen receptor hormonal pathway

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3776368

retrieved

12 September 2017

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1155%2F2013%2F761537

retrieved

21 January 2018

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24167368

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24167368

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

13 November 2016

1 reference

13 November 2016

1 reference

13 November 2016

ResearchGate publication ID

258117687

0 references

(Q21284776)

AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)